CN1209103C - 非诺贝特软胶囊及其制备方法 - Google Patents
非诺贝特软胶囊及其制备方法 Download PDFInfo
- Publication number
- CN1209103C CN1209103C CNB031482392A CN03148239A CN1209103C CN 1209103 C CN1209103 C CN 1209103C CN B031482392 A CNB031482392 A CN B031482392A CN 03148239 A CN03148239 A CN 03148239A CN 1209103 C CN1209103 C CN 1209103C
- Authority
- CN
- China
- Prior art keywords
- fenofibrate
- soft capsule
- polyethylene glycol
- weight
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 title claims abstract description 56
- 229960002297 fenofibrate Drugs 0.000 title claims abstract description 55
- 239000007901 soft capsule Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims description 9
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 21
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 20
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
- 239000002775 capsule Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 9
- 239000000084 colloidal system Substances 0.000 claims description 7
- 239000000758 substrate Substances 0.000 claims description 6
- 238000009413 insulation Methods 0.000 claims description 3
- 239000004531 microgranule Substances 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 abstract description 20
- 238000000338 in vitro Methods 0.000 abstract description 4
- 238000001727 in vivo Methods 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 7
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000007962 solid dispersion Substances 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- MZTKIKBXDMDCDY-UHFFFAOYSA-N 2-[4-(4-hydroxybenzoyl)phenoxy]-2-methylpropanoic acid Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1C(=O)C1=CC=C(O)C=C1 MZTKIKBXDMDCDY-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000007766 cera flava Substances 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010018873 Haemoconcentration Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 238000007922 dissolution test Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229940063823 fenofibrate 100 mg Drugs 0.000 description 1
- 229940020832 fenofibrate 200 mg Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- -1 hydroxypropyl Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031482392A CN1209103C (zh) | 2003-07-04 | 2003-07-04 | 非诺贝特软胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031482392A CN1209103C (zh) | 2003-07-04 | 2003-07-04 | 非诺贝特软胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1460471A CN1460471A (zh) | 2003-12-10 |
CN1209103C true CN1209103C (zh) | 2005-07-06 |
Family
ID=29591418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031482392A Expired - Fee Related CN1209103C (zh) | 2003-07-04 | 2003-07-04 | 非诺贝特软胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1209103C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103599089B (zh) * | 2013-11-18 | 2015-12-09 | 浙江爱生药业有限公司 | 非诺贝特油溶缓释药物制剂组合物 |
CN106265533A (zh) * | 2016-10-10 | 2017-01-04 | 朱隆娅 | 一种阿德呋啉颗粒剂及其制备方法 |
-
2003
- 2003-07-04 CN CNB031482392A patent/CN1209103C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1460471A (zh) | 2003-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1147472C (zh) | 具有组蛋白脱乙酰酶抑制剂活性的苯甲酰胺制剂 | |
CN1160079C (zh) | 发泡性肠溶制剂 | |
CN1309374C (zh) | 改进的快速崩解的多颗粒片剂 | |
CN1135103C (zh) | 经舌下或含服给药的控释药物 | |
CN1708269A (zh) | 用于奥昔布宁经皮治疗的组合物和方法 | |
CN1917859A (zh) | 载药纳米微粒及其制备方法以及含有该纳米微粒的非肠道给药用制剂 | |
CN1273194C (zh) | 水溶性差的活性物质的口服固溶体配方 | |
CN1209103C (zh) | 非诺贝特软胶囊及其制备方法 | |
CN1208345A (zh) | 包含托芬那酸或其医药可接受盐的快速释出片剂及其制法 | |
CN1965817A (zh) | 一种格列本脲缓释片制剂及其制备方法 | |
CN100341495C (zh) | 格列本脲固体分散体、口服组合物及其制备方法 | |
CN1265785C (zh) | 盐酸维拉帕米择时缓释制剂 | |
CN1771955A (zh) | 一种复方镇咳祛痰药物的软胶囊组合物 | |
CN102100679A (zh) | 卡洛芬骨架片 | |
CN101077351A (zh) | 含有罗红霉素的软胶囊 | |
CN1891256A (zh) | 一种冠心丹参分散片及其制备方法 | |
CN1919172A (zh) | 同载尼莫司汀及其增效剂的抗癌缓释剂 | |
CN1330537A (zh) | 含有普鲁芬的药物组合物 | |
CN1857220A (zh) | 一种抗结核病药物缓释剂 | |
CN1526379A (zh) | 盐酸西布曲明滴丸及其制备方法 | |
CN1732956A (zh) | 一种含有非那雄胺的药用软胶囊 | |
CN1857724A (zh) | 一种含抗结核病药物的缓释剂 | |
CN1973823A (zh) | 一种含增效剂的抗癌组合物 | |
CN1857218A (zh) | 含抗结核病药物的缓释剂 | |
CN1720975A (zh) | 细辛脑滴丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Aisheng Pharmaceutical Co., Ltd., Zhejiang Assignor: Hangzhou Zhaofeng Medicine Science & Technology Co., Ltd. Contract fulfillment period: 2009.11.3 to 2023.7.3 Contract record no.: 2009990001317 Denomination of invention: Fenofibrate soft capsule and its preparation method Granted publication date: 20050706 License type: Exclusive license Record date: 20091211 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.11.3 TO 2023.7.3; CHANGE OF CONTRACT Name of requester: ZHEJIANG ASEN PHARMACEUTICAL CO., LTD. Effective date: 20091211 |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190819 Address after: 750100 Multidimensional Pharmaceutical Family Hospital 003, Bianzhen, Yongning County, Yinchuan City, Ningxia Hui Autonomous Region Patentee after: Liu Qing Address before: 310012 Lianhuagang Home Building 2 Units 101, Wenhua Road, West Lake District, Hangzhou City, Zhejiang Province Patentee before: Hangzhou Zhaofeng Medicine Science & Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
DD01 | Delivery of document by public notice |
Addressee: Hangzhou Zhaofeng Medicine Science & Technology Co., Ltd. Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050706 Termination date: 20210704 |
|
CF01 | Termination of patent right due to non-payment of annual fee |